September 26, 2016
1 min read
Save

Five important news items from the American Society for Bone and Mineral Research Annual Meeting

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American Society for Bone and Mineral Research Annual Meeting, held in Atlanta earlier this month, produced a large amount of data from researchers from around the globe. Here, we present five important news items on Healio.com/Rheumatology.

Among the topics were sex steroids, hip fractures, diabetic bone disease and osteonecrosis. One of the top picks also details why the American Society for Bone and Mineral Research (ASBMR) Annual Meeting is a preferred conference for one of our editorial board members.

VIDEO: Promise of ‘-omics’ discussed at ASBMR Annual Meeting

Robert Blank, MD, PhD, an Endocrine Today Editorial Board member and chief of endocrinology at the Medical College of Wisconsin, explained why the American Society of Bone and Mineral Research (ASBMR) Annual Meeting is his preferred professional conference. Watch.

VIDEO: Long-term oral bisphosphonate use mildly increased risk for osteonecrosis of the jaw

Bo Abrahamsen, MD, PhD, professor and consultant endocrinologist at the Institute of Clinical Research, University of Southern Denmark in Odense, and Holbæk Hospital, Denmark, described the influence of treatment duration and adherence on the risk for osteonecrosis of the jaw or oral cavity in patients noted to be adherent, long-term users of oral bisphosphonates for osteoporosis. Watch.

VIDEO: Diabetic bone disease poses multiple avenues for research

Clifford J. Rosen, MD, director of clinical and translational research and a senior scientist at the University of Maine Medical Center’s Research Institute, described what is known about diabetic bone disease and what directions for research appear promising. Watch.

VIDEO: Reduced DXA reimbursement may lead to undiagnosed osteoporosis, hip fractures

E. Michael Lewiecki, MD, FACP, FACE, director of New Mexico Clinical Research and Osteoporosis Center in Albuquerque, discussed his study on the rate of hip fractures in the United States and the reduction in reimbursement for dual-energy X-ray absorptiometry (DXA) testing. Watch.

VIDEO: Decades of research point to therapies to discourage bone aging

Sundeep Khosla, MD, professor of medicine and physiology at Mayo Clinic in Rochester, Minnesota, discussed his work involving sex steroids, coupling and age-related bone and offered some clinical implications of the findings. Watch.